Literature DB >> 22215048

Mathematical modeling in immunotherapy of cancer: personalizing clinical trials.

Zvia Agur, Stanimir Vuk-Pavlović.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22215048      PMCID： PMC3255591          DOI： 10.1038/mt.2011.272

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  6 in total

1.  Rethinking clinical trials.

Authors:  Andrew Grove
Journal:  Science       Date:  2011-09-23       Impact factor: 47.728

Review 2.  Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications.

Authors:  Venkatesh A Bhattaram; Brian P Booth; Roshni P Ramchandani; B Nhi Beasley; Yaning Wang; Veneeta Tandon; John Z Duan; Raman K Baweja; Patrick J Marroum; Ramana S Uppoor; Nam Atiqur Rahman; Chandrahas G Sahajwalla; J Robert Powell; Mehul U Mehta; Jogarao V S Gobburu
Journal:  AAPS J       Date:  2005-10-07       Impact factor: 4.009

Review 3.  The FDA critical path initiative and its influence on new drug development.

Authors:  Janet Woodcock; Raymond Woosley
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

4.  Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables.

Authors:  Agnieska Michael; Graham Ball; Nadine Quatan; Fatima Wushishi; Nick Russell; Joe Whelan; Prabir Chakraborty; David Leader; Michael Whelan; Hardev Pandha
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

5.  Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models.

Authors:  Natalie Kronik; Yuri Kogan; Moran Elishmereni; Karin Halevi-Tobias; Stanimir Vuk-Pavlović; Zvia Agur
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

6.  Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical model.

Authors:  Boris Gorelik; Irit Ziv; Revital Shohat; Michael Wick; W David Hankins; David Sidransky; Zvia Agur
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701
  6 in total
  19 in total

1.  Mathematical model approach to describe tumour response in mice after vaccine administration and its applicability to immune-stimulatory cytokine-based strategies.

Authors:  Zinnia P Parra-Guillen; Pedro Berraondo; Emmanuel Grenier; Benjamin Ribba; Iñaki F Troconiz
Journal:  AAPS J       Date:  2013-04-19       Impact factor: 4.009

2.  Diagnostic assessment of osteosarcoma chemoresistance based on Virtual Clinical Trials.

Authors:  K A Rejniak; M C Lloyd; D R Reed; M M Bui
Journal:  Med Hypotheses       Date:  2015-06-24       Impact factor: 1.538

3.  From Fitting the Average to Fitting the Individual: A Cautionary Tale for Mathematical Modelers.

Authors:  Michael C Luo; Elpiniki Nikolopoulou; Jana L Gevertz
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

Review 4.  Computational oncology--mathematical modelling of drug regimens for precision medicine.

Authors:  Dominique Barbolosi; Joseph Ciccolini; Bruno Lacarelle; Fabrice Barlési; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

5.  Modeling cancer-immune responses to therapy.

Authors:  L G dePillis; A Eladdadi; A E Radunskaya
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-04       Impact factor: 2.745

6.  Target-mediated disposition model describing the dynamics of IL12 and IFNγ after administration of a mifepristone-inducible adenoviral vector for IL-12 expression in mice.

Authors:  Zinnia Patricia Parra-Guillen; Alvaro Janda; Pilar Alzuguren; Pedro Berraondo; Ruben Hernandez-Alcoceba; Iñaki F Troconiz
Journal:  AAPS J       Date:  2012-11-08       Impact factor: 4.009

Review 7.  Assessing the interactions between radiotherapy and antitumour immunity.

Authors:  Clemens Grassberger; Susannah G Ellsworth; Moses Q Wilks; Florence K Keane; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2019-06-26       Impact factor: 66.675

Review 8.  Systems Modeling to Quantify Safety Risks in Early Drug Development: Using Bifurcation Analysis and Agent-Based Modeling as Examples.

Authors:  Carmen Pin; Teresa Collins; Megan Gibbs; Holly Kimko
Journal:  AAPS J       Date:  2021-05-20       Impact factor: 4.009

9.  Personalizing immunotherapy: Balancing predictability and precision.

Authors:  Zvia Agur; Stanimir Vuk-Pavlović
Journal:  Oncoimmunology       Date:  2012-10-01       Impact factor: 8.110

10.  Kinetic and dynamic computational model-based characterization of new proteins in mice: application to interferon alpha linked to apolipoprotein A-I.

Authors:  Zinnia Patricia Parra-Guillen; Jessica Fioravanti; Jose Medina-Echeverz; Celia Gomar; Nuria Ardaiz; Iñaki F Troconiz; Pedro Berraondo
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.